Business
EO Care Appoints William Fleming and Kristi Savacool to Board of Directors, Reinforcing Its Leadership in Clinically Guided Cannabinoid Symptom Management
BOSTON, March 11, 2026--EO Care, Inc., a leading provider of clinically guided cannabinoid-based symptom management, today announced the appointment of William Fleming, PharmD, and Kristi Savacool to its Board of Directors. Both join as directors and investors, further strengthening the company’s governance, strategic depth, and national influence as cannabinoid care advances into mainstream healthcare delivery.
About this update from Humana Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/b9e9753a08441274acec4399dd3825a3"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/r2Xh4AEEfDHdgUJUv_LXMQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/b9e9753a08441274acec4399dd3825a3","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/cthx4U6EnAiwfukoDyf0hg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/b9e9753a08441274acec4399dd3825a3","width":1024,"height":512}},"lazy":false},{"type":"text","content":"Former Humana and Aon Hewitt executives join as directors and investors amid accelerating clinical validation, reimbursement expansion, and national growth.","length":156,"tagName":"p"},{"type":"text","content":"BOSTON, March 11, 2026--(BUSINESS WIRE)--EO Care, Inc., a leading provider of clinically guided cannabinoid-based symptom management, today announced the appointment of William Fleming, PharmD, and Kristi Savacool to its Board of Directors. Both join as directors and investors, further strengthening the company’s governance, strategic depth, and national influence as cannabinoid care advances into mainstream healthcare delivery.","length":432,"tagName":"p"},{"type":"text","content":"The appointments reflect EO Care’s leadership at a defining moment for the industry—marked by accelerating clinical validation, expanding reimbursement pathways, and growing demand from providers and health plans seeking accountable alternatives for complex symptom management.","length":277,"tagName":"p"},{"type":"text","content":"With the addition of Dr. Fleming and Ms. Savacool, EO Care’s Board of Directors and advisory leadership now include former U.S. Surgeon General Dr. Regina Benjamin and Dr. Jacob Strand, Enterprise Chair of the Center for Palliative Medicine at Mayo Clinic—forming a formidable group of nationally recognized healthcare executives and clinicians. Collectively, this leadership represents rare depth across federal health policy, value-based care, complex clinical delivery, and enterprise healthcare transformation, underscoring EO Care’s standing as a category-defining leader in clinically gu...